共 68 条
[1]
Theriault RL(2013)Breast cancer, version 3.2013: featured updates to the NCCN guidelines J Natl Compr Canc Netw. 11 753-760
[2]
Cardoso F(2014)ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) Ann Oncol. 25 1871-1888
[3]
Andre F(2004)Breast cancer with synchronous metastases: trends in survival during a 14-year period J Clin Oncol. 22 3302-3308
[4]
Mouridsen H(2003)The role of aromatase inhibitors in the treatment of metastatic breast cancer Semin Oncol. 30 33-45
[5]
Gershanovich M(2004)The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the MD Anderson Cancer Center evidence-based approach Cancer. 101 1482-1489
[6]
Morandi P(2008)Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer Trials. 9 47-816
[7]
Aydiner A(2013)Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Lancet. 381 805-3587
[8]
Tas F(2012)Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy J Clin Oncol. 30 3578-394
[9]
Davies C(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ. 339 b2700-998
[10]
Jim HS(2011)GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables J Clin Epidemiol. 64 383-5152